Neurocrine Biosciences (NBIX) Cash & Equivalents (2010 - 2026)
Neurocrine Biosciences (NBIX) posted Cash & Equivalents of $332.4 million for Q2 2026, up 25.9% from $264 million a year earlier and up 24.7% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences' Cash & Equivalents came in at $713 million, up 206.0% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 30.2% (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' Cash & Equivalents was $233 million in FY2024 (-10.1%), $259.1 million in FY2023 (-4.3%), $270.7 million in FY2022 (-21.3%) and $344 million in FY2021 (+80.8%).
- Quarterly Cash & Equivalents has run from a low of $103.8 million in Q1 2023 to a high of $713 million in Q4 2025 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with growth averaging 39.2% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2024, with growth of 281.8%; the weakest was Q1 2023, with a decline of 61.6%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $266.5 million (Q1 2026), $713 million (Q4 2025) and $340.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Neurocrine Biosciences | 14.30 Bn | 9.99 Bn | 935.80 Mn | 332.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 332.40 Mn |
| Mar 31, 2026 | 266.50 Mn |
| Dec 31, 2025 | 713.00 Mn |
| Sep 30, 2025 | 340.20 Mn |
| Jun 30, 2025 | 264.00 Mn |
| Mar 31, 2025 | 194.10 Mn |
| Dec 31, 2024 | 233.00 Mn |
| Sep 30, 2024 | 349.10 Mn |
| Jun 30, 2024 | 139.70 Mn |
| Mar 31, 2024 | 396.30 Mn |
| Dec 31, 2023 | 259.10 Mn |
| Sep 30, 2023 | 293.70 Mn |
| Jun 30, 2023 | 160.20 Mn |
| Mar 31, 2023 | 103.80 Mn |
| Dec 31, 2022 | 270.70 Mn |
| Sep 30, 2022 | 212.20 Mn |
| Jun 30, 2022 | 163.30 Mn |
| Mar 31, 2022 | 270.20 Mn |
| Dec 31, 2021 | 344.00 Mn |
| Sep 30, 2021 | 311.10 Mn |
API Access
Neurocrine Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();